ADVAMED
Medical device manufacturing trade association.
The register keeps a separate record of this client for every firm that files for it and every spelling of its name. All 13 of its records are shown together here.
Reported lobbying by year
Filings
| Filing | Filed by | Amount |
|---|---|---|
|
2nd Quarter - Report 2nd Quarter 2008
|
TARPLIN, DOWNS & YOUNG, LLC | $60,000 reported |
|
2nd Quarter - Report 2nd Quarter 2008
|
DDB ISSUES & ADVOCACY | — reported |
|
2nd Quarter - Report 2nd Quarter 2008
|
CAPITOL HILL STRATEGIES, LLC | $50,000 reported |
|
2nd Quarter - Report 2nd Quarter 2008
|
HEALTH POLICY ALTERNATIVES | $70,000 reported |
|
2nd Quarter - Reportreplaced 2nd Quarter 2008
|
EPSTEIN BECKER & GREEN, P.C. | — reported |
|
1st Quarter - Report 1st Quarter 2008
|
TARPLIN, DOWNS & YOUNG, LLC | $60,000 reported |
|
1st Quarter - Report 1st Quarter 2008
|
THE MCMANUS GROUP | $50,000 reported |
|
1st Quarter - Report 1st Quarter 2008
|
DDB ISSUES & ADVOCACY | — reported |
|
1st Quarter - Report 1st Quarter 2008
|
CAPITOL HILL STRATEGIES, LLC | $50,000 reported |
|
1st Quarter - Report 1st Quarter 2008
|
EPSTEIN BECKER & GREEN, P.C. | $40,000 reported |
Filed by
Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.
| Firm | Reports | Amount |
|---|---|---|
| TARPLIN, DOWNS & YOUNG, LLC | 57 | $4,060,000 |
| BROWNSTEIN HYATT FARBER SCHRECK, LLP | 7 | $1,400,000 |
| CAPITOL HILL STRATEGIES, LLC | 18 | $930,000 |
| HEALTH POLICY ALTERNATIVES | 8 | $740,150 |
| DLA PIPER LLP (US) | 23 | $650,000 |
| CGCN GROUP, LLC | 18 | $520,000 |
| OLSSON, FRANK, WEEDA, TERMAN & MATZ, PC | 11 | $520,000 |
| BLANK ROME GOVERNMENT RELATIONS | 10 | $380,000 |
| THE MCMANUS GROUP | 5 | $300,000 |
| EPSTEIN BECKER & GREEN, P.C. | 6 | $100,000 |
| SIGNAL GROUP CONSULTING, LLC | 2 | $40,000 |
| KIMBERLY OLSON DORGAN | 2 | $10,000 |
| DDB ISSUES & ADVOCACY | 6 | — |
Issues lobbied
How many report sections named each issue, counting the current version of each report.
| Issue | Code | Mentions |
|---|---|---|
| Health Issues | HCR | 103 |
| Medicare/Medicaid | MMM | 95 |
| Taxation/Internal Revenue Code | TAX | 85 |
| Budget/Appropriations | BUD | 48 |
| Environment/Superfund | ENV | 18 |
| Copyright/Patent/Trademark | CPT | 14 |
| Medical/Disease Research/Clinical Labs | MED | 8 |
| Trade (domestic/foreign) | TRD | 7 |
| Pharmacy | PHA | 4 |
Bills named in its filings
Bill numbers found in the filers' descriptions, most often named first.
| Bill | Congress | Times named |
|---|---|---|
| S. 232 | 113th | 13 |
| H.R. 523 | 113th | 13 |
| H.R. 1346 | 111th | 13 |
| S. 454 | 112th | 12 |
| H.R. 675 | 112th | 12 |
| H.R. 3762 | 114th | 10 |
| H.R. 452 | 112th | 10 |
| S. 2029 | 110th | 10 |
| S. 2221 | 110th | 10 |
| H.R. 436 | 112th | 9 |
| S. 17 | 112th | 9 |
| H.R. 3590 | 111th | 9 |
| S. 540 | 111th | 9 |
| H.R. 3162 | 110th | 9 |
| H.R. 2184 | 110th | 9 |
| S. 108 | 115th | 8 |
| S. 870 | 115th | 8 |
| H.R. 184 | 115th | 8 |
| S. 794 | 115th | 8 |
| H.R. 1021 | 114th | 8 |
| H.R. 160 | 114th | 8 |
| S.Con.Res. 11 | 114th | 8 |
| S. 149 | 114th | 8 |
| H.R. 3204 | 114th | 8 |
| H.R. 2 | 114th | 8 |
From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.